Twitter removed 800 followers from my account today. People have been writing saying twitter automatically unfollowed me for them. Follow me on Parler @robinmonotti & Telegram https://t.co/o5rFaSrCpa to bypass this.
https://t.co/NeZ1t39S1q
https://t.co/m70uj6vviC
Trust us not to turn over data. Trust us not to read your messages. Trust us not to close your channel. Maybe @Durov is an angel. I hope so! But angels have fallen before. Telegram should have been working to make channels decentralized\u2014meaning outside their control\u2014for years.
— Edward Snowden (@Snowden) December 30, 2017
https://t.co/QnfUzGiAW9
Think about this with reference to the media operation on Covid19.
A Telegram channel (amadnews) started to instruct their subscribers to use Molotov cocktails against police and got suspended due to our "no calls for violence" rule. Be careful \u2013 there are lines one shouldn't cross. Similar case from October \u2013 https://t.co/OWQFBLywjr
— Pavel Durov (@durov) December 30, 2017
https://t.co/i0MidqAR6i
Any chance you are going to change the flag of Great Britain as well? There are some good dystopian films to draw inspiration from. pic.twitter.com/qKp43zBiMi
— Pavel Durov (@durov) June 8, 2017
More from Robin Monotti
Italian researchers: vaccines will not work against SARSCoV2 because this virus does not only replicate in human cells like other viruses, this one replicates through bacteria too. This is the fundamental reason why antibiotics work & vaccines will not:
Here is the Italian-EU scientific study indicating SARSCoV2 replicates in bacteria, not only human cells, and that is why antibiotics work and these vaccines will not:
"The preliminary results suggest that SARS-CoV-2 replicates in bacterial
2 of the 4 authors of the study work at the European Commission. Another works at an Italian medical research facility called Craniomed: https://t.co/EETSM3nb3T
You can find all of CRANIOMED's Carlo Brogna's published scientific research articles here, take a look:
Here is the Italian-EU scientific study indicating SARSCoV2 replicates in bacteria, not only human cells, and that is why antibiotics work and these vaccines will not:
"The preliminary results suggest that SARS-CoV-2 replicates in bacterial
2 of the 4 authors of the study work at the European Commission. Another works at an Italian medical research facility called Craniomed: https://t.co/EETSM3nb3T
You can find all of CRANIOMED's Carlo Brogna's published scientific research articles here, take a look:
I have now re-examined this document:
It clearly does indicate both the risks of bacterial infection & to prescribe broad spectrum antibiotics as part of treatment:
"Collect blood cultures for bacteria that cause pneumonia and sepsis, ideally before antimicrobial therapy. DO NOT
delay antimicrobial therapy"
"6. Management of severe COVID-19: treatment of co-infections
Give empiric antimicrobials [broad spectrum antibiotics] to treat all likely pathogens causing SARI and sepsis as soon as possible, within 1 hour
of initial assessment for patients with sepsis."
"Empiric antibiotic treatment should be based on the clinical diagnosis (community-acquired
pneumonia, health care-associated pneumonia [if infection was acquired in health care setting] or sepsis), local epidemiology &
susceptibility data, and national treatment guidelines"
"When there is ongoing local circulation of seasonal influenza, empiric therapy with a neuraminidase inhibitor [anti-viral influenza drugs] should
be considered for the treatment for patients with influenza or at risk for severe disease."
On the 19th March 2020 the WHO released this guidance intended for healthcare workers (HCWs), healthcare managers and IPC teams at the facility level & at national and district/provincial level:https://t.co/C4aV2BnMPj pic.twitter.com/tCk1EyLskV
— Robin Monotti (@robinmonotti) December 21, 2020
It clearly does indicate both the risks of bacterial infection & to prescribe broad spectrum antibiotics as part of treatment:
"Collect blood cultures for bacteria that cause pneumonia and sepsis, ideally before antimicrobial therapy. DO NOT
delay antimicrobial therapy"
"6. Management of severe COVID-19: treatment of co-infections
Give empiric antimicrobials [broad spectrum antibiotics] to treat all likely pathogens causing SARI and sepsis as soon as possible, within 1 hour
of initial assessment for patients with sepsis."
"Empiric antibiotic treatment should be based on the clinical diagnosis (community-acquired
pneumonia, health care-associated pneumonia [if infection was acquired in health care setting] or sepsis), local epidemiology &
susceptibility data, and national treatment guidelines"
"When there is ongoing local circulation of seasonal influenza, empiric therapy with a neuraminidase inhibitor [anti-viral influenza drugs] should
be considered for the treatment for patients with influenza or at risk for severe disease."
The problem with meta-analysis like this is that it obfuscates the most important issue of treatment, which is timing.
This meta-analysis of controlled trials only looks at hospitalized patients. How long were the patients ill for before being hospitalized? One week? Two? Three? Too late for zinc ionophores (HCQ) (+ZINC? No zinc no point..) to work. Severe illness becomes bacterial in nature.
Was azythromycin administered when the bacterial infections were also too advanced? I have seen Azythromycin work with my very own eyes but that's not to say that if administered too late it may not save the patient. How many patients were given AZT & ventilated? It's all timing.
All the meta-analysis is telling us is if you leave it too late you may have missed the early window for antiviral zinc treatment (Zn+HCQ) & that if you are given AZT when you are ventilated or very severe it may too late for it to save you & corticosteroids may be last resort.
And of course antibiotics need also probiotics, or they may harm the bacterial flora which is part of the immune response. Difficult to tell from a meta-analysis how this problem was managed.
#BMJResearch update: Corticosteroids probably reduce mortality and mechanical ventilation in patients with covid-19 compared with standard care, whereas azithromycin, hydroxychloroquine, interferon-beta, and tocilizumab may not reduce either https://t.co/oQ3lTWUqaz
— The BMJ (@bmj_latest) December 18, 2020
This meta-analysis of controlled trials only looks at hospitalized patients. How long were the patients ill for before being hospitalized? One week? Two? Three? Too late for zinc ionophores (HCQ) (+ZINC? No zinc no point..) to work. Severe illness becomes bacterial in nature.
Was azythromycin administered when the bacterial infections were also too advanced? I have seen Azythromycin work with my very own eyes but that's not to say that if administered too late it may not save the patient. How many patients were given AZT & ventilated? It's all timing.
All the meta-analysis is telling us is if you leave it too late you may have missed the early window for antiviral zinc treatment (Zn+HCQ) & that if you are given AZT when you are ventilated or very severe it may too late for it to save you & corticosteroids may be last resort.
And of course antibiotics need also probiotics, or they may harm the bacterial flora which is part of the immune response. Difficult to tell from a meta-analysis how this problem was managed.
More from Twitter
Hey #optics and #photonics twitter
It's time again for the 2nd annual #top10photonics thread, where I compile my own #top10 best photonics papers list of the year!
See here for last year's thread:
https://t.co/6h82mPAn3w
A thread 👇
Same disclaimers as last time:
1. These aren't just papers that were published in 2020. They are papers that were added to my library in 2020. Some are a little older — some are a lot older. All are interesting or exciting to me in some way.
2. I reiterate - TO ME. This list is highly subjective, and is mostly about what captured my imagination most, not about what will make the biggest impact, or what is most worth funding. The order is mostly arbitrary too. This is just for fun :)
3. Once again I am NOT including any of my papers, or any from my current or former groups. If you're curious about what I do, drop a proverbial tip in my jar and peruse my publication list
And while I have your attention, register for #POM20ja, happening in 2 weeks. (It's free!) It's a completely reinvented @PhotonicsMeetup, and it promises to be a great time!
Now, on to the main event!
It's time again for the 2nd annual #top10photonics thread, where I compile my own #top10 best photonics papers list of the year!
See here for last year's thread:
https://t.co/6h82mPAn3w
A thread 👇
Hey #optics and #photonics twitter
— Orad Reshef (@Orad) December 29, 2019
It's the time of year where we are inundated in end-of-year top10 lists... but how many of those lists are made for _US_ and our community?
So I decided to compile my own #top10 best photonics papers list for 2019
A #top10photonics thread \U0001f447
Same disclaimers as last time:
1. These aren't just papers that were published in 2020. They are papers that were added to my library in 2020. Some are a little older — some are a lot older. All are interesting or exciting to me in some way.
2. I reiterate - TO ME. This list is highly subjective, and is mostly about what captured my imagination most, not about what will make the biggest impact, or what is most worth funding. The order is mostly arbitrary too. This is just for fun :)
3. Once again I am NOT including any of my papers, or any from my current or former groups. If you're curious about what I do, drop a proverbial tip in my jar and peruse my publication list
And while I have your attention, register for #POM20ja, happening in 2 weeks. (It's free!) It's a completely reinvented @PhotonicsMeetup, and it promises to be a great time!
Now, on to the main event!
After hearing about @JanelSGM from @csallen, I spent the past few hours digging into her Twitter feed to see how she has been building Newsletter OS in public, from ideation to launch.
Here are some highlights in chronological order and what you can learn from the process:
1/ August 5 2020: Janel digs into '50+ newsletters' (note the number to build credibility) and creates a thread to discuss the lessons learnt. She also mentions that this is for a side project, which raises awareness of something she may be working
2/ August 5 2020 (cont): Each tweet in the thread is focused on a key message, with clear pointers for newsletter writers to
3/ September 1 2020: Janel tweeted about #buildinginpublic (note the hashtag) with @pabloheredia24 for @makerpad's challenge. While the project is https://t.co/tMb1qCnxVY and not NewsletterOS, Janel is getting in the reps on how to build in
4/ October 18 2020: Janel hints at building her new product using @NotionHQ and @gumroad. But instead of telling the audience directly what the product is, she invites her audience to take a guess.
Here are some highlights in chronological order and what you can learn from the process:
1/ August 5 2020: Janel digs into '50+ newsletters' (note the number to build credibility) and creates a thread to discuss the lessons learnt. She also mentions that this is for a side project, which raises awareness of something she may be working
Just subscribed to 50+ newsletters in the past hour
— Janel (@JanelSGM) August 4, 2020
(for a side project)
Here are some lessons I've learned
Thread \U0001f447
2/ August 5 2020 (cont): Each tweet in the thread is focused on a key message, with clear pointers for newsletter writers to
1/ Clear Value Proposition
— Janel (@JanelSGM) August 4, 2020
Do you articulate clearly the following?
- What content you write about
- Who your newsletter is for
- How your audience will benefit from your newsletter?
3/ September 1 2020: Janel tweeted about #buildinginpublic (note the hashtag) with @pabloheredia24 for @makerpad's challenge. While the project is https://t.co/tMb1qCnxVY and not NewsletterOS, Janel is getting in the reps on how to build in
4/ October 18 2020: Janel hints at building her new product using @NotionHQ and @gumroad. But instead of telling the audience directly what the product is, she invites her audience to take a guess.
I've been launching a product a month, with the aim of launching 12 in 12 months (w/ @LaunchMBA)
— Janel (@JanelSGM) October 18, 2020
This month, I'll be launching an actionable info product.
Core Tools: @NotionHQ @gumroad
Want to guess what I'll launch?
Free copy for the first person who guesses right.
